Login / Signup

Generalized myasthenia gravis with acetylcholine receptor antibodies: A guidance for treatment.

Nils Erik GilhusHenning AndersenLinda Kahr AndersenMarion BoldinghSini M LaaksoMargret Oddny LeopoldsdottirSidsel MadsenFredrik PiehlTrine Haug PopperudAnna Rostedt PungaLiselotte SchirakowJohn Vissing
Published in: European journal of neurology (2024)
Successful treatment of MG rests on timely combination of different interventions. Due to spontaneous disease fluctuations, comorbidities, and changes in life conditions, regular long-term specialized follow-up is needed. Most patients do reasonably well but there is room for further improvement. Novel treatments are promising, though subject to restricted access due to costs.
Keyphrases
  • myasthenia gravis
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • prognostic factors
  • peritoneal dialysis
  • palliative care